Related Experiment Video
Updated: Jan 12, 2026

Assessment of Social Interaction Behaviors
Published on: February 25, 2011
Altered acetylcholine modulations and corticoaccumbal pathway in P11-linked social dysfunction
Daniel Dautan1, Anderson Camargo2, Niclas Branzell2
1Department of Clinical Neuroscience, Karolinska Institute, Stockholm, Sweden. daniel.dautan@ki.se.
None:
Social relationships rely on the willingness to interact with others and the ability to interpret their emotional cues. Major depressive disorder (MDD) often leads to dysfunctional social interactions, marked by reduced social motivation and difficulties in recognizing emotions, yet these issues remain inadequately explored despite their significant impact on quality of life. These social behaviors, interconnected through the corticoaccumbal pathway, balance anxiety and social interaction, but the underlying mechanisms remain poorly understood. Notably, the calcium-binding protein S100A10 (also known as P11), which is dysregulated in MDD patients and influences the response to antidepressants, is prominently expressed in brain structures involved in social and emotional processing. Here, we demonstrate that chronic restraint stress alters P11 expression along the corticoaccumbal circuit. Additionally, our genetic model, P11-knockout mice, exhibit depression-like behavior, including a reduction of social motivation and impaired recognition of conspecific emotions. Using in vivo and ex vivo electrophysiology, we reveal that P11 expression modulates the response of the corticoaccumbal pathway, influencing the balance between anxiety and social interaction, as well as emotion recognition by regulating dopamine and acetylcholine release in the accumbens. Interestingly, we pinpoint the role of different cholinergic structures in anxiety, social motivation, and emotion recognition. Finally, we show that the prosocial compound oxytocin and social buffering therapy were able to rescue the socially impaired behaviors following chronic stress or P11 ablation, opening new avenues for potential treatments.
Related Concept Videos
Attention-Deficit/Hyperactivity Disorder
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....
Alzheimer's Disease: Overview
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
Causes of Social Behavior II: Cognitive Processes

